8b7w: Difference between revisions
m Protected "8b7w" [edit=sysop:move=sysop] |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
==Complex IL-17A/anti-IL-17A-76== | |||
<StructureSection load='8b7w' size='340' side='right'caption='[[8b7w]], [[Resolution|resolution]] 2.85Å' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>[[8b7w]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [https://en.wikipedia.org/wiki/Lama_glama Lama glama]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=8B7W OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=8B7W FirstGlance]. <br> | |||
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.85Å</td></tr> | |||
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=8b7w FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=8b7w OCA], [https://pdbe.org/8b7w PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=8b7w RCSB], [https://www.ebi.ac.uk/pdbsum/8b7w PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=8b7w ProSAT]</span></td></tr> | |||
</table> | |||
== Function == | |||
[https://www.uniprot.org/uniprot/IL17_HUMAN IL17_HUMAN] Induces stromal cells to produce proinflammatory and hematopoietic cytokines. Enhances the surface expression of ICAM1/intracellular adhesion molecule 1 in fibroblasts. | |||
<div style="background-color:#fffaf0;"> | |||
== Publication Abstract from PubMed == | |||
Interleukin-17 (IL-17) is a cytokine produced by the Th17 cells. It is involved in chronic inflammation in patients with autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, and psoriasis. The antibodies targeting IL-17 and/or IL-17R are therapy tools for these diseases. Netakimab is an IL-17A-specific antibody containing a Lama glama V(H)H derivative domain and a VL variable domain. We have determined the crystal structure of the IL-17A-specific V(H)H domain in complex with IL-17A at 2.85 A resolution. Certain amino acid residues of the three complementary-determining regions of the V(H)H domain form a network of solvent-inaccessible hydrogen bonds with two epitope regions of IL-17A. The beta-turn of IL-17A, which forms the so-called epitope-1, appears to be the main region of IL-17A interaction with the antibody. Contacts formed by the IL-17A mobile C-terminal region residues (epitope-2) further stabilize the antibody-antigen complex. | |||
Two Epitope Regions Revealed in the Complex of IL-17A and Anti-IL-17A V(H)H Domain.,Kostareva O, Svoeglazova A, Kolyadenko I, Nikulin A, Evdokimov S, Dzhus U, Gabdulkhakov A, Tishchenko S Int J Mol Sci. 2022 Nov 28;23(23):14904. doi: 10.3390/ijms232314904. PMID:36499233<ref>PMID:36499233</ref> | |||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |||
[[Category: | </div> | ||
[[Category: | <div class="pdbe-citations 8b7w" style="background-color:#fffaf0;"></div> | ||
[[Category: Dzhus | |||
[[Category: | ==See Also== | ||
[[Category: Kolyadenko | *[[Interleukin 3D structures|Interleukin 3D structures]] | ||
[[Category: | == References == | ||
[[Category: Svoeglazova | <references/> | ||
__TOC__ | |||
</StructureSection> | |||
[[Category: Homo sapiens]] | |||
[[Category: Lama glama]] | |||
[[Category: Large Structures]] | |||
[[Category: Dzhus UF]] | |||
[[Category: Gabdulkhakov AG]] | |||
[[Category: Kolyadenko IA]] | |||
[[Category: Kostareva OS]] | |||
[[Category: Svoeglazova A]] | |||
[[Category: Tishchenko SV]] | |||
Latest revision as of 16:39, 1 February 2024
Complex IL-17A/anti-IL-17A-76Complex IL-17A/anti-IL-17A-76
Structural highlights
FunctionIL17_HUMAN Induces stromal cells to produce proinflammatory and hematopoietic cytokines. Enhances the surface expression of ICAM1/intracellular adhesion molecule 1 in fibroblasts. Publication Abstract from PubMedInterleukin-17 (IL-17) is a cytokine produced by the Th17 cells. It is involved in chronic inflammation in patients with autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, and psoriasis. The antibodies targeting IL-17 and/or IL-17R are therapy tools for these diseases. Netakimab is an IL-17A-specific antibody containing a Lama glama V(H)H derivative domain and a VL variable domain. We have determined the crystal structure of the IL-17A-specific V(H)H domain in complex with IL-17A at 2.85 A resolution. Certain amino acid residues of the three complementary-determining regions of the V(H)H domain form a network of solvent-inaccessible hydrogen bonds with two epitope regions of IL-17A. The beta-turn of IL-17A, which forms the so-called epitope-1, appears to be the main region of IL-17A interaction with the antibody. Contacts formed by the IL-17A mobile C-terminal region residues (epitope-2) further stabilize the antibody-antigen complex. Two Epitope Regions Revealed in the Complex of IL-17A and Anti-IL-17A V(H)H Domain.,Kostareva O, Svoeglazova A, Kolyadenko I, Nikulin A, Evdokimov S, Dzhus U, Gabdulkhakov A, Tishchenko S Int J Mol Sci. 2022 Nov 28;23(23):14904. doi: 10.3390/ijms232314904. PMID:36499233[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See AlsoReferences
|
| ||||||||||||||||||